Background: CO2 inhalation reduces central sleep apnea (CSA) in patients with congestive heart failure (CHF) and idiopathic CSA. CO2 is also a stimulus for cortical arousal, which has been linked to increased sympathetic nerve activity (SNA) and increased mortality in CHF patients with CSA. Objective: We have tested the hypothesis that during sleep, inhalation of CO2 sufficient to reduce the apnea-hypopnea index (AHI) would not reduce the arousal index (AroI). Methods: In 10 male patients with CSA (7 with CHF and 3 with idiopathic CSA), the inspired CO2 concentration was increased to raise the sleeping end-tidal CO2 by 2–4 mm Hg during established stage 2 sleep. Each intervention was maintained for a 10-min period. Sleep stage was monitored with electroencephalograms, electrooculograms, submental electromyogram, airflow with pneumotachometer and respiratory effort and blood gases with oxygen saturation and end-tidal CO2. During periods of air and CO2 breathing, AHI and AroI were compared with paired t tests; patients acted as their own controls. Results: Inhalation of CO2 produced a significant reduction in AHI (mean ± SEM) from 74.4 ± 12.4 events/h during air breathing to 25.8 ± 7.8 events/h with CO2 inhalation (p = 0.002). However, the AroI was not significantly different between the two conditions, air 67.8 ± 12.3 events/h and CO2 inhalation 52.8 ± 12.4 events/h (p = 0.264). Conclusion: CO2 inhalation reverses CSA but not arousals from sleep. Our findings highlight the need for treatment options that reduce both respiratory events and decrease arousals from sleep, with their associated SNA sequelae.

Keywords:
Arousals, Breathing, Central sleep apnea, Congestive heart failure
1.
Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H, Roselle GA: Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995;122:487–492.
2.
Naughton MT: Pathophysiology and treatment of Cheyne-Stokes respiration. Thorax 1998;53:514–518.
3.
Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101–1106.
4.
Hanly P, Zuberi N, Gray R: Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure: Relationship to arterial PCO2. Chest 1993;104:1079–1084.
5.
Naughton MT, Benard DC, Tam A, Rutherford R, Bradley TD: Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 1993;148:330–338.
6.
Xie A, Rutherford R, Rankin F, Wong B, Bradley TD: Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Respir Crit Care Med 1995;152:1950–1955.
7.
Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA: Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 2002;165:245–1250.
8.
Findley LJ, Zwillich CW, Ancoli-Israel S, Kripke D, Tisi G, Moser KM: Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 1985;78:11–15.
9.
Steens RD, Millar TW, Su X, Biberdorf D, Buckle P, Ahmed M, Kryger MH: Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep 1994;17:61–68.
10.
Andreas S, Weidel K, Hagenah G, Heindl S: Treatment of Cheyne-Stokes respiration with nasal carbon dioxide. Eur Respir J 1998;12:414–419.
11.
Lorenzi-Filho G, Rankin F, Bies I, Bradley TD: Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999;159:1490–1498.
12.
Xie A, Rankin F, Rutherford R, Bradley TD: Effects of inhaled CO2 and dead space on idiopathic central sleep apnea. J Appl Physiol 1997;82:918–926.
13.
Cohn JN, Levine TB, Olivari MT, Garberg V, Laura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819–823.
14.
Leimbach WN, Gunner WB, Victor RG, Aylward PE, Sundlof G, Mark AL: Direct evidence from intraneural recordings for increased sympathetic outflow in patients with heart failure. Circulation 1986;73:913–919.
15.
Hanly PJ, Zuberi-Khokhar NS: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996;153:272–276.
16.
Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:1435–1440.
17.
Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995;152:473–479.
18.
Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD: Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 1994;150:489–495.
19.
Task Force of the American Sleep Disorders Association: EEG arousals: Scoring and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:174–184.
20.
Wilcox I, McNamara SG, Dodd MJ, Sullivan C: Ventilatory control in patients with sleep apnea with left ventricular dysfunction: Comparison of obstructive and central sleep apnea. Eur Respir J 1998;11:7–13
21.
Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT: Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 2000;162:2194–2200.
22.
Ayas NT, Brown R, Shea SA: Hypercapnia can induce arousal from sleep in the absence of altered respiratory mechanoreception. Am J Respir Crit Care Med 2000;162:1004–1008.
23.
Naughton MT, Rahman AM, Hara K, Floras JS, Bradley TD: Effects of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995;91:1725–1731.
24.
Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 1990;82:I35–I43.
25.
Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730–1736.
26.
Morgan BJ, Crabtree DC, Puleo DS, Badra SM, Toiber F, Skatrud JB: Neurocirculatory consequences of abrupt change in sleep state. J Appl Physiol 1996;80:1627–1636.
27.
Morrell MJ, Finn L, Kim H, Peppard PE, Badr MS, Young T: Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based study. Am J Respir Crit Care Med 2000;162:2091–2096.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.